VitaPath Genetics

About:

VitaPath Genetics develops DNA tests to help individuals reduce the risk of serious and life-threatening diseases.

Top Investors: Mohr Davidow Ventures, XSeed Capital

Description:

VitaPath Genetics is developing a family of DNA tests to help individuals reduce the risk of serious and life-threatening disease. Their first product is a genetic test to identify risk factors that are associated with a common birth defect called Spina Bifida and which can be safely corrected with low-risk vitamin supplementation under the care of a physician.

Total Funding Amount:

$19.9M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Foster City, California, United States

Founded Date:

2009-01-01

Contact Email:

info(AT)vpgenetics.com

Founders:

Bruce Cohen

Number of Employees:

11-50

Last Funding Date:

2012-08-06

IPO Status:

Private

Industries: